Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Blue-Light glasses and standing breaks fix your screen time health?

NCT ID NCT06963736

Recruiting now Symptom relief Sponsor: Arizona State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether easy home-based strategies—like wearing blue-light blocking glasses, standing for 10 minutes each hour, and not eating after 8pm—can reduce the negative health effects of evening screen time. Researchers will track 30 adults with obesity or prediabetes who spend at least 3 hours on screens after 5pm. The goal is to see if these habits are acceptable and can improve blood sugar control and reduce sedentary time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Blue light blocking glasses, standing breaks, and early eating cutoff
What this could lead to
If it works, this could point toward easy, home-based habits to lower blood sugar and heart disease risk from too much screen time.
What could go wrong
This is a very small, early feasibility study with only 30 people, so results may not apply widely. The strategies are simple but may be hard to stick with long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Obesity obesity disorder prediabetes syndrome Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES OBESITY PREDIABETES SEDENTARY TIME

Contacts and locations

Locations

  • Arizona State University

    RECRUITING

    Tempe, Arizona, 85281, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.